Comparison of fluorine-18-FDG with rest-redistribution thallium-201 SPECT to delineate viable myocardium and predict functional recovery after revascularization

Journal of Nuclear Medicine

Volumn 39, Issue 9, 1998, Pages 1481-1486

  Bax, Jeroen J ^a   Cornel, Jan H ^b   Visser, Frans C ^b   Fioretti, Paolo M ^b   Van Lingen, Arthur ^b   Huitink, Johannes M ^b   Elhendy, Abdou ^b   Poldermans, Don ^b   Roelandt, Jos R T C ^b   Visser, Cees A ^b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

Fluorine 18 fluorodeoxyglucose; Myocardial viability; Rest redistribution; SPECT; Thallium 201

Indexed keywords

FLUORODEOXYGLUCOSE F 18; THALLIUM 201;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; ECHOCARDIOGRAPHY; FEMALE; FUNCTIONAL ASSESSMENT; HEART FUNCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; MALE; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TISSUE DISTRIBUTION;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ARTERY BYPASS; ECHOCARDIOGRAPHY; FEMALE; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; HEART; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MIDDLE AGED; MYOCARDIAL STUNNING; PREDICTIVE VALUE OF TESTS; RADIOPHARMACEUTICALS; ROC CURVE; SENSITIVITY AND SPECIFICITY; THALLIUM RADIOISOTOPES; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0031659981     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Dilsizian V, Bonow RO. Current diagnostic techniques of assessing viability in patients with hibernating and stunned myocardium. Circulation 1993;87:1-20.
2. Tillisch J, Brunken R, Marshall R, et al. Reversibility of cardiac wall motion abnormalities predicted by positron tomography. N Engl J Med 1986;314:884-888.
3. 201Tl imaging in detection of myocardial viability and prediction of improvement in left ventricular function after coronary bypass surgery in patients with severely depressed left ventricular function. Circulation 1993;87:1630-1641.
4. Tamaki N, Yonekura Y, Yamashita K, et al. Positron emission tomography using fluorine-18 deoxyglucose in evaluation of coronary artery bypass grafting. Am J Cardiol 1989;64:860-865.
5. Nienaber CA, Brunken RC, Sherman CT, et al. Metabolic and functional recovery of ischemic human myocardium after coronary angioplasty. J Am Coll Cardiol 1991;18: 966-978.
6. Marwick TH, MacIntyre WJ, Lafont A, Nemec JJ, Salcedo EE. Metabolic responses of hibernating and infarcted myocardium to revascularization. Circulation 1992;85:1347-1353.
7. Knuuti MJ, Nuutila P, Ruotsalainen U, et al. The value of quantitative analysis of glucose utilization in detection of myocardial viability by PET. J Nucl Med 1993;34: 2068-2075.
8. Maes A, Flameng W, Nuyts J, et al. Histological alterations in chronically hypoperfused myocardium. Correlation with PET findings. Circulation 1994;90:735-745.
9. Vom Dahl J, Eitzman DT, Al-Aouar ZR, et al. Relation of regional function, perfusion and metabolism in patients with advanced coronary artery disease undergoing surgical revascularization. Circulation 1994;90:2356-2366.
10. 18F-fluorodeoxyglucose using single photon emission computed tomography. Eur Heart J 1993;14:1675-1682.
11. Bax JJ, Visser FC, van Lingen A, et al. Relation between myocardial uptake of thallium-201 chloride and fluorine-18 fluorodeoxyglucose imaged with single-photon emission tomography in normal individuals. Eur J Nucl Med 1995;22:56-60.
12. Bax JJ, Visser FC, Blanksma PK, et al. Comparison of myocardial uptake of fluorine-18-fluorodeoxyglucose imaged with PET and SPECT in dyssynergic myocardium. J Nucl Med 1996;37:1631-1636.
13. Martin WH, Delbeke D, Patton JA, et al. FDG-SPECT: correlation with FDG-PET. J Nucl Med 1995;36:988-995.
14. Sandler MP, Videlefsky S, Delbeke D, et al. Evaluation of myocardial ischemia using a rest metabolism/stress perfusion protocol with fluorine-18 deoxyglucose/technetium-99m MIBI and dual-isotope simultaneous-acquisition single-photon emission computed tomography. J Am Coll Cardiol 1995;26:870-888.
15. Burt RW, Perkins OW, Oppenheim BE, et al. Direct comparison of fluorine-18-FDG SPECT, fluorine-18-FDG PET and rest thallium-201 SPECT for the detection of myocardial viability. J Nucl Med 1995;36:176-179.
16. Berger BC, Watson DD, Burwell LR, et al. Redistribution of thallium at rest in patients with stable and unstable angina and the effect of coronary artery bypass surgery. Circulation 1979;60:1114-1125.
17. Gewirtz H, Beller GA, Strauss HW, et al. Transient defect of resting thallium scans in patients with coronary artery disease. Circulation 1979;53:707-713.
18. Dilsizian V, Perrone-Filardi P, Arrighi JA, et al. Concordance and discordance between stress-redistribution-reinjection and rest-redistribution thallium imaging for assessing viable myocardium. Comparison with metabolic activity by positron emission tomography. Circulation 1993;88:941-952.
19. Mori T, Minamiji K, Kurogane H, Ogawa K, Yoshida Y. Rest-injected thallium-201 imaging for assessing viability of severe asynergic regions. J Nucl Med 1991;32:1718-1724.
20. Iskandrian AS, Hakki A, Kane SA, et al. Rest and redistribution thallium-201 myocardial scintigraphy to predict improvement in left ventricular function after coronary arterial bypass grafting. Am J Cardiol 1983;51:1312-1316.
21. Alfieri O, La Canna G, Giubbini R, Pardini A, Zogno M, Fucci C. Recovery of myocardial function. Eur J Cardiothorac Surg 1993;7:325-330.
22. Knuuti J, Nuutila P, Ruotsalainen U, et al. Euglycemic hyperinsulinemic clamp and oral glucose load in stimulating myocardial glucose utilization during positron emission tomography. J Nucl Med 1992;33:1255-1262.
23. Phelps ME, Hoffman EJ, Selin C, et al. Investigation of [18F]2-fluoro-2-deoxyglucose for the measure of myocardial glucose metabolism. J Nucl Med 1978;19:1311-1319.
24. van Lingen A, Huijgens PC, Visser FC, et al. Performance characteristics of a 511-keV collimator for imaging positron emitters with a standard gamma-camera. Eur J Nucl Med 1992;19:315-321.
25. Bax JJ, Cornel JH, Visser FC, et al. Functional recovery after revascularization predicted by quantitative FDG SPECT [Abstract]. Eur J Nucl Med 1995;22:798.
26. Righetti A, Crawford MH, O'Rourke RA, et al. Interventricular septal motion and left ventricular function after coronary bypass surgery: evaluation with echocardiography and radionuclide ventriculography. Am J Cardiol 1977;39:372-377.
27. Tennant R, Wiggers CJ. The effect of coronary occlusion on myocardial contraction. Am J Physiol 1935;112:351-361.
28. Ross J Jr. Myocardial perfusion-contraction matching: implications for coronary heart disease and hibernation. Circulation 1991;83:1076-1083.
29. Rahimtoola SH. The hibernating myocardium. Am Heart J 1989;117:211-221.
30. Vanoverschelde JLJ, Wijns W, Depre C, et al. Mechanisms of chronic regional postischemic dysfunction in humans. New insights from the study of noninfarcted collateral-dependent myocardium. Circulation 1993;87:1513-1523.
31. Marinho NVS, Keogh BE, Costa DC, Lammertsma AA, Ell PJ, Camici PG. Pathophysiology of chronic left ventricular dysfunction. New insights from the measurement of absolute myocardial blood flow and glucose utilization. Circulation 1996;93:737-744.
32. Mäki M, Luotolahti M, Nuutila P, et al. Glucose uptake in the chronically dysfunctional but viable myocardium. Circulation 1996;93:1658-1666.
33. Conversano A, Walsh JF, Geltman EM, Perez JE, Bergmann SR, Gropler RJ. Delineation of myocardial stunning and hibernation by positron emission tomography in advanced coronary artery disease. Am Heart J 1996;131:440-450.
34. Arnese M, Cornel JH, Salustri A, et al. Prediction of improvement of regional left ventricular function after surgical revascularization: a comparison of low-dose dobutamine echocardiography with 201-Tl SPECT. Circulation 1995;91:2748-2752.
35. Vanoverschelde J-LJ, D'Hondt A-M, Marwick T, et al. Head-to-head comparison of exercise-redistribution-reinjection thallium single-photon emission computed tomography and low dose dobutamine echocardiography for prediction of reversibility of chronic left ventricular ischemic dysfunction. J Am Coll Cardiol 1996;28:432-442.
36. Gerber BL, Vanoverschelde J-LJ, Bol A, et al. Myocardial blood flow, glucose uptake and recruitment of inotropic reserve in chronic left ventricular ischemic dysfunction. Implications for the pathophysiology of chronic hibernation. Circulation 1996;94:651-659.
37. DeFilippi CR, Willett DWL, Irani WN, Eichhorn EJ, Velasco CE, Grayburn PA. Comparison of myocardial contrast echocardiography and low-dose dobutamine stress echocardiography in predicting recovery of left ventricular function after coronary revascularization in chronic ischemic heart disease. Circulation 1995;92:2863-2868.
38. Smart SC. The clinical utility of echocardiography in the assessment of myocardial viability. J Nucl Med 1994;35(suppl):49S-58S.
39. 18K-labeled fluorodeoxyglucose and N-13 ammonia. Circulation 1983;67:766-778.
40. Camici P, Araujo L, Spinks T, et al. Increased uptake of 18-F-fluorodeoxyglucose in postischemic myocardium of patients with exercise-induced angina. Circulation 1986;74:81-88.
41. Maddahi J, Schelbert H, Brunken R, Di Cadi M. Role of thallium-201 and PET imaging in evaluation of myocardial viability and management of patients with coronary artery disease and left ventricular dysfunction. J Nucl Med 1994;35:707-715.
42. Melin JA, Becker LC. Quantitative relationship between global left ventricular thallium uptake and blood flow: effects of propranolol, ouabain, dipyridamole and coronary artery occlusion. J Nucl Med 1986;27:641-652.
43. Pohost GM, Zir LM, Moore RH, McKusick KA, Guiney TE, Beller GA. Differentiation of transiently ischemic from infarcted myocardium by serial imaging after a single dose of thallium-201. Circulation 1977;55:294-302.
44. Sansoy V, Glover DK, Watson DD, et al. Comparison of thallium-201 resting redistribution with technetium-99m-sestamibi uptake and functional response to dobutamine for assessment of myocardial viability. Circulation 1995;92:994-1004.
45. 201Tl activity in irreversible defects as a marker of myocardial viability. Clinicopathological study. Circulation 1995;91: 1016-1021.
46. De Maria R, Parodi O, Baroldi G, et al. Morphological bases for thallium-201 uptake in cardiac imaging and correlates with myocardial blood flow distribution. Eur Heart J 1996;17:951-961.
47. Tamaki N, Mukai T, Ishii Y, et al. Comparative study of thallium emission myocardial tomography with 180° and 360° data collection. J Nucl Med 1982;23:661-666.
48. Go RT, MacIntyre WJ, Houser TS, et al. Clinical evaluation of 360° and 180° data sampling techniques for transaxial SPECT thallium-201 myocardial perfusion imaging. J Nucl Med 1985;26:695-706.
49. Kennedy JW, Kaiser GC, Fisher LD, et al. Clinical and angiographic predictors of operative mortality from the collaborative study in coronary artery surgery (CASS). Circulation 1981;63:793-802.
50. Alderman EL, Fisher LD, Litwin P, et al. Results of coronary artery surgery in patients with poor left ventricular function (CASS). Circulation 1983;68:785-795.
51. Pigott JD, Kouchoukos NT, Oberman A, Cutter GR. Late results of surgical and medical therapy for patients with coronary artery disease and depressed left ventricular function. J Am Coll Cardiol 1985;5:1036-1045.